Trial Profile
Long term study of everolimus eluting stents for the prevention of allograft vasculopathy in patients with orthotopic heart transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 23 Dec 2015 New trial record